In: 新闻报道

Ancillare, a diversity supplier for the clinical trial ancillary supply chain, secures capital amidst the COVID-19 pandemic.

 

HORSHAM, Pa. — May 13, 2020. Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, today announced it has closed a multi-million dollar debt financing deal with Fulton Bank.

“To secure funds in debt financing in the midst of the COVID-19 pandemic is a significant accomplishment,” said Dr. Joanne Santomauro, Chief Executive Officer. “It presents an exciting opportunity to further shape the future of the Clinical Trial Ancillary Supply Chain at a time when innovation couldn’t be more critical.”

Ancillare, a WBENC certified woman-owned business, has serviced the global Clinical Trial Ancillary Supply Chain (CTASC) for nearly 15 years. The new funds will enable progress towards the organization’s growth initiatives as well as the company’s long-term diversification strategies. The financing presents an opportunity for Ancillare to strengthen its technology platform with robust data and predictive analytics programs, expand its global footprint with new vertical offerings, and enhance customer experiences across all services. Additionally, the company plans to initiate an acquisition strategy to further expand globally.

“Fulton Bank is committed to expanding our specialization in the Life Sciences and Technology industry. Our relationship with Ancillare is an opportunity for us to support a thriving local life sciences organization that is performing a critical function during this worldwide health care crisis,” said Lou Lombardi, Southeastern Pennsylvania commercial market executive and senior vice president for Fulton Bank. “Providing these funds enables innovation, which gives hope for a healthier future.”

“I have full confidence in Fulton – the bank is an excellent partner, and one who understands our business,” Santomauro added. “Fulton Bank embraces our company’s mission and vision which in turn will result in Ancillare’s ability to deliver quicker, better, and more efficient programs to our sponsors.”

As a diversity supplier and strategic partner to many of the top global pharmaceutical and biotechnology companies, Ancillare’s current initiatives are largely focused on developing technology-based solutions for its clients. Recently, the company announced the launch of its Digital Communications Platform, which gives sponsors and their partners predictive insights into the CTASC for their portfolio of studies. The funds secured in partnership with Fulton Bank will allow Ancillare to expand its technology offerings and execute forward-thinking, industry-shaping initiatives.

About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with corporate offices in the United States and United Kingdom, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Netherlands, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com.

About Fulton Bank, NA
Fulton Bank, N.A. is a subsidiary of Fulton Financial Corporation, a $22 billion Lancaster, Pa.-based financial holding company, has approximately 3,600 employees and operates approximately 230 branches in Pennsylvania, Maryland, Delaware, New Jersey and Virginia through Fulton Bank, N.A. Additional information on Fulton Bank can be found at www.fultonbank.com.

HORSHAM, Pa. — April 8, 2020. Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, today announced the launch of its new Ancillare Digital Communications Platform (ADCP).

ADCP is an interactive communications Portal that marries Ancillare’s 16 years of rich clinical trial ancillary supply data with AI, analytics, and collaboration technology. The Platform will provide sponsors with real time predictive insights into the Clinical Trial Ancillary Supply Chain (CTASC).

This Platform, built by Ancillare’s technology team, will offer sponsors a central access point to track the flow of ancillary supplies in their clinical trials. Its key capabilities will include inventory information and alerts, shipment tracking, real-time document collaboration, trend analysis and forecasting, EDI and sponsor single sign-on functionality.

The announcement follows the appointment of Ancillare’s new Vice President of Global Information Technology and Infrastructure, Deighton Liverpool. Under his guidance, Ancillare’s leadership team is executing on plans to further streamline the ancillary supply chain through innovative technologies.

“The launch of ADCP marks a critical moment in Ancillare’s history,” said Dr. Joanne Santomauro, Chief Executive Officer. “Our goal to become a technology-driven supply chain organization relies on the ability to integrate our industry-defining process with forward-thinking technologies.”

In the coming weeks, Ancillare will make the first version of ADCP available to its clients. The organization plans to expand upon the core functionalities later in 2020. For future updates regarding ADCP, please visit ancillare.com

 
About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with corporate offices in the United States and United Kingdom, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, The Netherlands, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com

HORSHAM, Pa. — March 17, 2020. Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, today announced it has appointed Deighton Liverpool to Vice President of Global Information Technology and Infrastructure.

Reporting to Dominick Vietri, President, Liverpool will be responsible for delivering mission-critical results by developing and implementing strategies related to Infrastructure, Application Development, Data Analytics, Business Intelligence, and Data Visualization for Ancillare’s industry-leading suite of Ancillary Supply Chain Management solutions.

“Deighton’s experience and knowledge will be a great asset to the organization,” said Vietri. “He has developed a rich career as an IT leader who creates strategic alliances with organizations and is recognized for his ability to build high performance teams.”

Prior to joining Ancillare, Liverpool held several high-ranking positions spanning all aspects of IT strategy and implementation, as well as staff management and development. Most recently, Liverpool was Global Head of IT for Invidi Technologies, an AT&T company. However, several of his roles gained him experience in healthcare and adjacent fields, including Chief Technology Officer at the American Association for Cancer Research, Chief Information Officer at AVCP, and Systems Engineer/Technical Project Leader at Trigon Blue Cross Blue Shield. His career has comprised a number of other business verticals, including finance, insurance, government, retail and manufacturing. As a hobby, he moonlighted as an On-Air Radio personality, hosting two music shows on WPLZ (Richmond, VA) and KYUK (Bethel, AK).

Liverpool holds a Bachelor of Business Administration in Management Information Systems from Pace University. He has also earned two graduate certificates: one in Information Technology Management from Georgia Institute of Technology, and another in Organizational Change Management from the University of Virginia. He has been a featured speaker at notable technology conferences such as the Gartner Symposium and WICT Philadelphia.

“Through his vision, leadership, and executive insight, Deighton will be instrumental in propelling Ancillare to become a technology-driven supply chain organization,” said Dr. Joanne Santomauro, Chief Executive Officer. “We are glad to welcome him aboard.”

 
About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with corporate offices in the United States, United Kingdom, and Singapore, and distribution hubs in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit Ancillare.com.
 
Contact: Courtney Wright
              Director, Marketing
Tel:       +1.215.515.9541
Email:   courtney.wright@ancillare.com

Danielle Frederick, former Senior Director of Quality Assurance, joins the executive leadership team at Ancillare, LP.

 

Horsham, PA – January 27th, 2020 Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, announced it has appointed Danielle Frederick to Vice President of Clinical and Business Operations.

Reporting to Dominick Vietri, President, Frederick will provide global leadership and strategic direction to enhance the organization’s clinical operations, global distribution and supply chain management initiatives. Frederick is tasked with developing, implementing and executing policies, procedures, programs and services designed to minimize risk and enable compliant business operations.

Since joining the organization in May 2018, Frederick has played an integral role in enhancing quality focus throughout the Ancillare organization.

Frederick brings extensive experience as a diverse quality professional with a strong focus on global quality management. Prior to Ancillare, Danielle served in various quality management positions at West Pharmaceutical Services and Fisher Clinical Services, specializing in quality audits, supplier quality, document control and training. Frederick holds a Bachelor of Science in Business Administration from the California Coast University and maintains multiple certifications, including the Executive Leadership Certificate from Cornell University, ASQ Certified Quality Auditor and Certified Manager of Quality and Organizational Excellence.

“Danielle has been vital in strengthening our ability to deliver the best-in-class ancillary supply chain management services for our clients,” said Dr. Joanne Santomauro, Chief Executive Officer. “We’re delighted to welcome Danielle to the executive leadership team.”

 

About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network, advanced technology, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, Europe, and Asia-Pacific, and strategic depots in Argentina, Australia, Brazil, Canada, China, Israel, Japan, Korea, Mexico, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit ancillare.com.

Horsham, PA – September 25, 2019 Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, announced the appointment of Dominick Vietri as its new President.

Vietri will oversee the day-to-day operations of the global organization. Vietri will provide global leadership and strategic direction to enhance the organization’s objectives to becoming a High-Performance Organization, which will deliver excellence, drive growth, and high-performance culture to our clients.

Vietri brings over 25 years of executive management and leadership experience in operations, sales, and marketing, across small to midsize wireless telecommunication, technology, and Fortune 500 companies.

Prior to Ancillare, Vietri held numerous executive and senior leadership positions, including Executive Vice President at Medifast a subsidiary of Jason Pharmaceuticals, Vice President of Sales at OfficeMax, Regional Vice President and General Manager at Canon Business Solutions, Chief Operations Officer at Intergis, Chief Executive Officer and President at Accelacom, Area Vice President and General Manager at XO Communications Group Vice President and General Manager at AT&T Wireless Services, and earlier in his career, Vietri held various positions at XEROX Corporation.

 “Vietri’s extensive executive leadership experience will strengthen our ability to deliver the best-in-class clinical and ancillary supply chain management services for our clients,” said Dr. Joanne Santomauro, Chief Executive Officer. “Vietri will be an integral part in moving our organization’s mission and vision forward.”

Vietri succeeds Jonathan Santomauro, who has moved to Chief Strategy Officer for the organization.

 

About Ancillare, LP

Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine.

HORSHAM, PA. — June 13, 2019 Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, today announced it will sponsor a summer education program offered by the Young Men and Women in Charge (YMWIC) Foundation Inc.

The sponsorship will cover tuition expenses for two students from disadvantaged families to attend a Science, Technology, Engineering and Math (STEM) summer program. Since 2007, YMWIC has served underprivileged youth in Philadelphia and surrounding communities through education and leadership programs geared toward preparation for careers in STEM fields.

“Ancillare is proud to support an organization doing such important work for youth in our community,” said Dr. Joanne Santomauro, Ancillare CEO and YMWIC board member. “The students who attend these programs are preparing to become industry innovators, not unlike those who brought Ancillare into existence.”

“We wish the very best to the families who will benefit from our sponsorship, and look forward to continuing to give back to our community,” Santomauro added.

About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in the United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit Ancillare.com.

About YMWIC
YMWIC was founded in 2007 and is designed to support and expose youth to STEM education. Our mission is to empower and prepare economically disadvantaged and historically underrepresented youth to excel and become leaders in Science, Technology, Engineering and Math (STEM) careers through academic tutoring, mentoring and financial assistance programs accomplished by leveraging alliances with K-12 school districts, universities, corporations, and our committed partners. To learn more visit ymwicfoundation.org.

HORSHAM, PA. — May 21, 2018. Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the first organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, announced today its Chief Executive Officer and Founder, Joanne Santomauro, has received an Executive Doctorate of Business Administration (DBA) from the Fox School of Business at Temple University.

The doctoral degree, which was conferred May 9 at the university’s Liacouras Center in Philadelphia, is the capstone to three years’ work involving academic rigor, executive mentorship, and extensive primary research. Dr. Santomauro completed her studies while continuing to oversee day-to-day operations of the global organization. The commencement ceremony was an emotional and gratifying moment for Dr. Santomauro and her family, who were also in attendance.

“I’m very proud of this accomplishment and what it means for the trajectory of our organization,” said Dr. Santomauro. “In addition to the invaluable insights gained by my research, Ancillare will benefit from an extended network of accomplished Fox peers in healthcare and supply chain management.”

“I can’t wait to see where we go from here,” added Dr. Santomauro, who intends to continue to conduct both scholarly and practitioner research geared to test new theories and produce new knowledge that will deepen the understanding of this complex supply chain.

The findings of Dr. Santomauro’s research are chronicled in her dissertation, entitled “An Exploration of the Global Clinical Trial Ancillary Supply Chain and the Drivers of Success During the Pre, In, and Post Phases.” Dr. Santomauro also successfully defended her dissertation earlier this Spring in partial fulfillment of the requirements of the doctoral program. Scholars and executives who steered and approved Dr. Santomauro’s work include:

  • Misty Blessley, Advisory Chair, Marketing and Supply Chain Management
  • Anthony Di Benedetto, Professor, Marketing and Supply Chain Management
  • Edward Rosenthal, Professor, Marketing and Supply Chain Management
  • Lynne Andersson, Associate Professor, Human Resources Management

Dr. Santomauro also said, “I’d like to personally thank my family, my friends, and my entire team at Ancillare for supporting me as I completed my doctorate, and for your continued commitment to and belief in our mission that ultimately helps patients live longer and more productive lives.”

Dr. Santomauro intends to publish her research findings in several practitioner journals in the upcoming months.

About Ancillare, LP
Ancillare is the first organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in the United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit Ancillare.com.

About the Fox School of Business
Temple University’s Fox School of Business is the largest, most comprehensive business school in the Philadelphia region and among the largest in the world, with more than 9,000 students, 220 full-time faculty and 60,000 alumni around the globe. The Fox School has a proud tradition of delivering innovative, entrepreneurial programs for the past 100 years. With facilities that provide access to market-leading technologies, the school fosters a collaborative and creative learning environment. Coupled with its leading student services, the Fox School ensures that its graduates are fully prepared to make a real impact in the real world. Learn more at Fox.Temple.edu.

HORSHAM, Pa. — December 5, 2018. Global Clinical and Ancillary Supply Chain leader Ancillare, LP, the only organization exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations, announced today its Chief Executive Officer and Founder, Joanne Santomauro, has been recognized by the Philadelphia Business Journal as a 2018 Most Admired CEO honoree.

The Most Admired CEO award recognizes the top Chief Executive Officers who are established leaders with a strong record of innovation in their field, outstanding financial performance, a commitment to quality, a strong vision, a culture of diversity in the workplace and contributions to the Greater Philadelphia region. The honorees for 2018 were selected by the Philadelphia Business Journal editorial board.

“It is an honor to be recognized among this dynamic list of leaders,” said Santomauro. “It is my privilege to be the CEO of such a talented, dedicated group of professionals. Our growth and success would not be possible without my incredible team.”

Santomauro defined and revolutionized clinical and ancillary supply chain management for the clinical research industry in 2006 after recognizing a gap. Under Santomauro’s inspirational leadership, Ancillare transformed the way sponsors manage their clinical and ancillary supply chains. Ancillare has grown from a start-up organization to a global organization with over 200 employees around the world.

Today, global pharmaceutical, biotechnology and medical device companies, as well as contract and medical research organizations, turn to Ancillare to manage their Phase I-IV trial clinical and ancillary supply demands.

Santomauro will be honored at an award ceremony at The Ritz Carlton in Philadelphia on Thursday, December 6, 2018.

 
 
About Ancillare, LP

Ancillare is the only organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.

Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine. To learn more, visit ancillare.com.

 
Contact: Courtney Wright
              Director, Marketing
Tel:       +1.215.515.9541
Email:   courtney.wright@ancillare.com

 美国宾州,霍舍姆 — 2018年5月18日。 安永会计师事务所 (Ernst & Young) 已宣布Joanne Santomauro为大费城地区年度企业家奖®2018决赛选手,Joanne Santomauro是Ancillare, LP公司的创始人兼CEO,该公司是为制药、生物技术、外包研发和医疗研究机构提供端到端全球临床试验辅助供应链管理服务的领导者。

该奖项旨在表彰那些在创新、财务业绩以及对企业和社区的个人承诺等方面表现出色的企业家。Santomauro被一组独立评委选为决赛选手。

“因为我的前瞻性思维和创新而被大家认可为决赛选手真是一种荣幸,”Santomauro说道:“我很幸运,能够成功地为各个赞助组织管理全球临床供应链,并成为开发创新地、挽救生命的疗法贡献一份力量,为患者服务。”

在Santomauro鼓舞人心的领导下,Ancillare公司从2006年的创业组织发展成为行业领导者,定义并改变了生命科学行业对临床和辅助供应链的认知和管理方式。

这个奖项已进入第32个年头,现已扩展到全球145多个城市和60多个国家的商业领袖。区域奖获得者有资格参加年度企业家全国竞赛 – 战略增长论坛®的高潮环节,它是高增长的市场领先公司的全国最具声望的聚会。

区域奖获奖者将于6月14日星期四在Kimmel表演艺术中心举行的特别盛会上宣布。11月10日将在加利福尼亚州棕榈泉举行的年度企业家奖颁奖典礼上宣布多个国家类别的获奖者以及年度企业家全国总奖。

赞助商
年度企业家奖由安永创办和制作,由SAP America,Merrill Corporation和Ewing Marion Kauffman Foundation在美国全国赞助。在大费城,赞助商还包括PNC银行,Pine Hill集团,Murray Devine & 公司,SolomonEdwardsGroup, Ballard Spahr LLP, Morgan, Lewis & Bockius LLP, Pepper Hamilton LLP和Simkiss & Block。

关于Ancillare, LP
Ancillare是唯一一家专注于全球临床和辅助供应链的组织。Ancillare通过定制的端到端Ancillare供应计划,为全球临床试验的赞助商助力,使新疗法的开发人员能够使用简化的流程,广泛的全球购买力,庞大的仓库网络和经过验证的临床,采购,运营,物流和监管专家团队,优化其临床研究供应链 。Ancillare的一站式运营(A-TKO™)模式通过降低临床试验的总体成本和周期时间,并大大提高价值链各个层面的运营效率,可同时应对临床和辅助供应链的复杂性和全球化。

Ancillare已在100多个国家的80000个临床站点支持了1500多项临床试验,其中包括美国,英国和新加坡的主供应站,以及阿根廷,澳大利亚,巴西,加拿大,智利,中国,哥伦比亚,印度,以色列,日本,韩国,墨西哥,巴拿马,秘鲁,菲律宾,俄罗斯,南非,台湾和乌克兰的战略供应站。要了解更多信息,请访问ancillare.com

关于年度企业家奖®
年度企业家奖®由安永会计师事务所创立,是世界上最负盛名的企业家商业奖项计划,由独立评审团组成,包括企业家和商界,金融界和当地社区的知名领袖。该计划通过鼓励有潜力的人进行创业活动的方式发挥作用,并认可那些以自己的愿景、领导力和成就激励他人的人的贡献。作为同类型中第一个也是唯一一个真正的全球奖项计划,年度企业家庆祝那些正在打造并领导成功的、不断发展的和充满活力的企业的人们,在超过145个城市和60多个国家,以地区奖项,国家奖项和全球奖计划来表彰他们的贡献。请访问 ey.com/eoy了解更多信息。

关于安永的增长市场网络
安永的全球增长市场网络致力于满足高增长公司不断变化的需求。30多年来,我们帮助世界上许多最具活力并雄心勃勃的公司成长为市场领导者。无论是与国际中型企业合作还是早期风险投资支持的企业,我们的专业人士都会利用他们丰富的经验,洞察力和全球资源来帮助您的企业取得成功。更多信息请访问我们的网站ey.com/sgm 或在Twitter上关注我们@EY_Growth

关于安永
安永是保险,税务,交易和咨询服务的全球领导者。我们提供的见解和优质服务有助于建立对资本市场和全球经济体的信任和信心。我们培养杰出的领导者,他们团结一致,向所有利益相关者兑现我们的承诺。通过这样做,我们在为员工,客户和社区建立更好的工作环境方面发挥着关键作用。

安永指的是全球组织,也可能指Ernst&Young全球有限公司的一个或多个成员公司,每个成员公司都是一个独立的法人实体。Ernst&Young全球有限公司是一家英国有限责任公司,不向客户提供服务。欲了解更多与我们组织有关的信息,请访问ey.com。

本新闻由Ernst & Young LLP发布,即全球安永组织的成员之一,旨在向美国的客户提供服务。更多信息请访问ey.com

Jonathan Santomauro对公司和社区的奉献精神受到认可,入选《费城商业期刊》的活力进取新星名单并获得表彰。

美国宾州,霍舍姆—2018年4月17日 全球临床和辅助供应链领导者Ancillare, LP,唯一一家专门为大中型制药、生物技术和医疗器械公司以及外包研发和医疗研究机构提供端到端临床和辅助供应链管理服务的组织,很高兴地宣布其总裁兼联合创始人Jonathan Santomauro被《费城商业期刊》评为“2018年40岁以下40大杰出人物”之一。

“40岁以下40大杰出人物”表彰的是费城地区当前及未来的优秀领导者,认可他们的专业卓越,杰出成就和对社区的贡献。Santomauro从400多个提名者中脱颖而出。

Santomauro在确定对临床和辅助供应链行业的单一焦点方面发挥了重要作用,并且最特别的是,他被视作Ancillare 一站式运营(A-TKO™)端到端解决方案背后的驱动主力,这已经彻底改变了行业对临床供应链的处理方式。通过这种和其他商业模式,Ancillare将继续保持在全球临床供应链行业的最前沿,并将继续对临床试验操作,时间线,现场表现和最终患者体验产生直接影响。

Ancillare已从最初的创业组织发展成为一个在全世界各地雇员多达200多人的全球组织。定义并改变了生命科学行业对临床和辅助供应链的感知和管理方式。如今,全球十大顶级制药公司中的八家,全球五大顶级生物技术公司中的三家以及顶尖的两大临床研究机构,都选择让Ancillare管理自己的I-IV阶段临床试验和辅助供应需求。

“能被评选为《费城商业期刊》“40岁以下40大杰出人物”之一是一种荣誉,”Santomauro说: “我很幸运能够为全球各地患者的临床试验操作和创新疗法的发展带去直接影响。”

Santomauro活跃于当地商业社区,他是YPO(前青年主席组织)费城分会的成员,还是康奈尔大学的创业咨询委员会的长期成员,并在那里获得了工商管理硕士学位和文学学士学位。

Santomauro将于5月10日星期四在费城SugarHouse赌场举行的颁奖典礼上领奖。

关于Ancillare, LP

Ancillare是唯一一家专注于全球临床和辅助供应链的组织。Ancillare通过定制的端到端Ancillare供应计划,为全球临床试验的赞助商助力,使新疗法的开发人员能够使用简化的流程,广泛的全球购买力,庞大的仓库网络和经过验证的临床,采购,运营,物流和监管专家团队,优化其临床研究供应链 。Ancillare的一站式运营(A-TKO™)模式通过降低临床试验的总体成本和周期时间,并大大提高价值链各个层面的运营效率,可同时应对临床和辅助供应链的复杂性和全球化。

Ancillare已在100多个国家的80000个临床站点支持了1500多项临床试验,其中包括美国,英国和新加坡的主供应站,以及阿根廷,澳大利亚,巴西,加拿大,智利,中国,哥伦比亚,印度,以色列,日本,韩国,墨西哥,巴拿马,秘鲁,菲律宾,俄罗斯,南非,台湾和乌克兰的战略供应站。要了解更多信息,请访问Ancillare.com